Charles River Laboratories International, Inc. (NYSE: CRL) last traded at $295.19, up 1.28% on the session. The quote above updates while this page is open; the figures below are drawn from Charles River Laboratories International, Inc.’s own filings and are restated only when a new one is published.
Charles River Laboratories International, Inc. trades on NYSE under the ticker CRL. Its market capitalisation is $14.09 billion.
Valuation measures for Charles River Laboratories International, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $14.09B |
|---|---|
| Enterprise value | $18.54B |
| Price / sales | 3.52 |
| Price / book | 4.96 |
| Beta | 1.24 |
Trailing-twelve-month figures tagged in Charles River Laboratories International, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $4.00B |
|---|---|
| Net income (TTM) | -$238.46M |
| EPS (TTM) | -$4.80 |
| Operating margin | 2.25% |
| Return on equity | -8.40% |
| Cash | $192.03M |
Range and volume for CRL over the past 52 weeks.
| 52-week high | $299.32 |
|---|---|
| 52-week low | $144.26 |
| Volume | 757.8K |
| Average volume | 899.3K |
| Previous close | $291.45 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.